Literature DB >> 18434662

Two doses of azithromycin to eliminate trachoma in a Tanzanian community.

Anthony W Solomon, Emma Harding-Esch, Neal D E Alexander, Aura Aguirre, Martin J Holland, Robin L Bailey, Allen Foster, David C W Mabey, Patrick A Massae, Paul Courtright, John F Shao.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18434662      PMCID: PMC6837862          DOI: 10.1056/NEJMc0706263

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  4 in total

1.  Pooling of Chlamydia laboratory tests to determine the prevalence of ocular Chlamydia trachomatis infection.

Authors:  J Diamant; R Benis; J Schachter; J Moncada; F Pang; H C Jha; R C Bhatta; T Porco; T Lietman
Journal:  Ophthalmic Epidemiol       Date:  2001-07       Impact factor: 1.648

2.  Field evaluation of a rapid point-of-care assay for targeting antibiotic treatment for trachoma control: a comparative study.

Authors:  Claude-Edouard C Michel; Anthony W Solomon; Jose P V Magbanua; Patrick A Massae; Ling Huang; Jonaice Mosha; Sheila K West; Elpidio C B Nadala; Robin Bailey; Craig Wisniewski; David C W Mabey; Helen H Lee
Journal:  Lancet       Date:  2006-05-13       Impact factor: 79.321

3.  Mass treatment with single-dose azithromycin for trachoma.

Authors:  Anthony W Solomon; Martin J Holland; Neal D E Alexander; Patrick A Massae; Aura Aguirre; Angels Natividad-Sancho; Sandra Molina; Salesia Safari; John F Shao; Paul Courtright; Rosanna W Peeling; Sheila K West; Robin L Bailey; Allen Foster; David C W Mabey
Journal:  N Engl J Med       Date:  2004-11-04       Impact factor: 91.245

4.  Strategies for control of trachoma: observational study with quantitative PCR.

Authors:  Anthony W Solomon; Martin J Holland; Matthew J Burton; Sheila K West; Neal D E Alexander; Aura Aguirre; Patrick A Massae; Harran Mkocha; Beatriz Muñoz; Gordon J Johnson; Rosanna W Peeling; Robin L Bailey; Allen Foster; David C W Mabey
Journal:  Lancet       Date:  2003-07-19       Impact factor: 79.321

  4 in total
  47 in total

1.  Active trachoma and ocular Chlamydia trachomatis infection in two Gambian regions: on course for elimination by 2020?

Authors:  Emma M Harding-Esch; Tansy Edwards; Ansumana Sillah; Isatou Sarr; Chrissy H Roberts; Paul Snell; Esther Aryee; Sandra Molina; Martin J Holland; David C W Mabey; Robin L Bailey
Journal:  PLoS Negl Trop Dis       Date:  2009-12-22

2.  Importance of including borderline cases in trachoma grader certification.

Authors:  Bruce D Gaynor; Abdou Amza; Sintayehu Gebresailassie; Boubacar Kadri; Baido Nassirou; Nicole E Stoller; Sun N Yu; Puja A Cuddapah; Jeremy D Keenan; Thomas M Lietman
Journal:  Am J Trop Med Hyg       Date:  2014-07-07       Impact factor: 2.345

Review 3.  Advancing the public health applications of Chlamydia trachomatis serology.

Authors:  Sarah C Woodhall; Rachel J Gorwitz; Stephanie J Migchelsen; Sami L Gottlieb; Patrick J Horner; William M Geisler; Catherine Winstanley; Katrin Hufnagel; Tim Waterboer; Diana L Martin; Wilhelmina M Huston; Charlotte A Gaydos; Carolyn Deal; Magnus Unemo; J Kevin Dunbar; Kyle Bernstein
Journal:  Lancet Infect Dis       Date:  2018-07-05       Impact factor: 25.071

4.  What is causing active trachoma? The role of nonchlamydial bacterial pathogens in a low prevalence setting.

Authors:  Matthew J Burton; Victor H Hu; Patrick Massae; Sarah E Burr; Caroline Chevallier; Isaac A Afwamba; Paul Courtright; Helen A Weiss; David C W Mabey; Robin L Bailey
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-07-29       Impact factor: 4.799

5.  Trachoma rapid assessments in Unity and Northern Bahr-el-Ghazal States, Southern Sudan.

Authors:  Emily Robinson; Lucia W Kur; Aggrey Ndyaba; Mounir Lado; Juma Shafi; Emmanuel Kabare; R Scott McClelland; Jan H Kolaczinski
Journal:  PLoS One       Date:  2010-10-01       Impact factor: 3.240

6.  Profound and sustained reduction in Chlamydia trachomatis in The Gambia: a five-year longitudinal study of trachoma endemic communities.

Authors:  Matthew J Burton; Martin J Holland; Pateh Makalo; Esther A N Aryee; Ansumana Sillah; Sandra Cohuet; Angels Natividad; Neal D E Alexander; David C W Mabey; Robin L Bailey
Journal:  PLoS Negl Trop Dis       Date:  2010-10-05

7.  The natural history of trachoma infection and disease in a Gambian cohort with frequent follow-up.

Authors:  Nicholas C Grassly; Michael E Ward; Shirley Ferris; David C Mabey; Robin L Bailey
Journal:  PLoS Negl Trop Dis       Date:  2008-12-02

Review 8.  Strategies to control trachoma.

Authors:  Anu A Mathew; Angus Turner; Hugh R Taylor
Journal:  Drugs       Date:  2009-05-29       Impact factor: 9.546

9.  Importance of coverage and endemicity on the return of infectious trachoma after a single mass antibiotic distribution.

Authors:  Takele Lakew; Wondu Alemayehu; Muluken Melese; Elizabeth Yi; Jenafir I House; Kevin C Hong; Zhaoxia Zhou; Kathryn J Ray; Travis C Porco; Bruce D Gaynor; Thomas M Lietman; Jeremy D Keenan
Journal:  PLoS Negl Trop Dis       Date:  2009-08-25

10.  When can antibiotic treatments for trachoma be discontinued? Graduating communities in three African countries.

Authors:  Kathryn J Ray; Thomas M Lietman; Travis C Porco; Jeremy D Keenan; Robin L Bailey; Anthony W Solomon; Matthew J Burton; Emma Harding-Esch; Martin J Holland; David Mabey
Journal:  PLoS Negl Trop Dis       Date:  2009-06-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.